DermAIM – our cloud-based AI engine for skin cancer diagnostics and seamless integration

Placeholder image of Dermalyser in use.

DermAIM

DermAIM is the AI engine powering Dermalyser – a CE-marked medical software (MDSW) that provides clinical decision support for the assessment of suspicious skin lesions. DermAIM runs in the cloud and is designed for seamless integration into existing telemedicine platforms and electronic health record (EHR) systems, allowing healthcare professionals to use AI support within their existing workflows.

How DermAIM fits into your environment

  • ArrowCloud API: DermAIM delivers risk assessments (e.g., melanoma probability) through secure API calls once a dermoscopic image has been captured within your workflow.
  • ArrowTelemedicine and EHR-ready: The setup is designed to plug into teledermatology systems, provider portals and EHRs, ensuring that results and metadata are automatically linked back to the patient record.
  • ArrowModern interoperability: The architecture is built for easy integration with established healthcare IT systems, following industry standards for data exchange and API communication.
Placeholder image.

Typical Workflow

1. Image and data: A clinician captures a dermoscopic image using a smartphone and dermatoscope. 2. Analysis in DermAIM: The image is securely analysed in the cloud. 3. Result returned: A risk score and decision support output are sent back to the telemedicine or EHR system.

Why choose DermAIM

Evidence before hype: Clinically validated in primary care – the setting where most initial skin assessments take place. Integration-first design: Cloud deployment and API architecture enable easy implementation without disrupting existing workflows.

Placeholder image.